#AANAM MGH Neurology Brigham and Women's Neurology Mass General Brigham/HMS Neurology Residency on the books and in the books!

A Prospective Randomized Trial of Direct Oral Anticoagulant Therapy with A Fully Magnetically Levitated LVAD: The DOT-HM3 Study | Circulation ahajournals.org/doi/10.1161/CI…
The ISHLT plenary presentation! Ivan Netuka Mandeep R. Mehra, MBBS, MSc, FRCP (London) Peter Ivak Zuzana Tucaniva 😀 colleagues

We are pleased to inform that our DOT-HM3 Trial results in partnership between IKEM and The Brigham Harvard just got online! Our results suggest a safety signal of Apixaban use with the HM3 up to a 6-months time point in stable LVAD patients. ahajournals.org/doi/abs/10.116…

Enjoyed immersion into the RV today! Excellent talks by Sergio Caravita Ryan J Tedford MD Archer Martin. Esp needed waveform review & managemt of RV preload, afterload, contractility & lusitrophy. RV/LV interdependence & coupling is a dynamic feature of VAD pts The ISHLT #ISHLT2024

After being in heels for over two days I switched into my ASICS and couldn’t be happier. Loved dinner at SuSuZa and a quick walk in Old Town with JeanConnorsMD and Lara. Prague is really special ✨

Team pics from day 2 @ #ISHLT2024 How great is it that our Brigham crew is composed of clinicians from advanced heart failure, infectious dis, hematology, & even surgery (that’s our honorary BWH surgeon Ivan Netuka 😁) MultiD @ its finest Michael Givertz Ann Woolley Mandeep R. Mehra, MBBS, MSc, FRCP (London)

A thorough overview of LVAD driveline infections presented by Ann Woolley including immune dysregulation in the host, imaging options including nuclear imaging, and adjunctive tx w cold plasma and phage therapy. We look forward to more data to come in this field! 🦠🔬 #ISHLT2024

Always great to catch up with Shivank and hear of the amazing work he is doing Montefiore Health System! Looking forward to hearing him present disparity data in OHT patients. Brigham AHFTC fellows are the best 👏🏻Mandeep R. Mehra, MBBS, MSc, FRCP (London)

Fascinating talk given by Ivan Netuka on VAD inflow cannula (IC) position as a predictor for ischemic stroke and also HF readmission #ISHLT2024

Love hearing Dr Melana Yuzefpolskaya & Manreet Kanwar speak re: NET PROLONGATION of life strategies; let’s stop pitting VAD vs OHT and think of them as therapies to potentially be used in tandem, not necessarily in parallel #ISHLT2024

Manreet Kanwar presents powerful data on improving both quality and duration of life in LVAD patients. Optimize hemodynamics. GDMT for remission/recovery. Monitor drive line like it’s a “third limb.” Silver, chlorhexadine, and stringent diabetes control. #ishlt2024 The ISHLT

really wish this wasnt the first thing i saw this morning

Hemodynamic RAMP optimization data of patients with HM3 VADs with considerably lower all-cause hospitalization ColumbiaCardiology Nir Uriel, MD MSc #THT2024

Women as One “You CAN have it all. Just not all at the same time.” - Shelley Hall
One of the best pieces of advice I’ve received. Has helped me be kinder to myself, and learn that it’s important to re-evaluate priorities at major turning points in life.
Women in Heart Transplantation and MCS

My first year @ #THT2024 and I couldn’t be more proud to learn amongst my colleagues & mentors, and of course listen to fantastic discussion re: the relevance of LVAD therapy -let us not “forget” about this valuable support Francesco Castagna Michael Givertz Maya H. Barghash, MD Mandeep R. Mehra, MBBS, MSc, FRCP (London)

Had an amazing time tonight with the Basaria sisters & the American Heart Association raising awareness of heart disease in women

Heart disease is the leading cause of death in women and 59% of Black women over the age of 19 have cardiovascular disease 😔

Know your numbers ladies 🫀💃🏽❤️